Editorial Policies

 

Principles of Transparency and Best Practice in Scholarly Publishing

This Journal strives to adhere to the Principles of Transparency and Best Practice in Scholarly Publishing could be found in the DOAJ website completely, for details please check here.

This Journal has established a guideline for editorial independence as delineated below. The guideline generally follows that created by the World Association of Medical Editors.

  1. This Journal is operated by Scivision Publishing Group LLC, which is publishing organization.

  2. The General Chief Editor is responsible for independent leadership of This Journal editorial operations. The General Publishing Editor reports to the Editor-in-Chief for all editorial matters.

  3. Each individual Journal of Scivision Publishing Group LLC has one or more Editor-in-Chief. These Editors-in-Chief each have their own boards.

  4. The Editor-in-Chief has full authority over the content of This Journal and its related offerings. This includes summaries and comments on recent medical advances, opinions, blogs and news

  5. Content-related decisions are based on quality, importance, and value to the users of This Journal . Contributing authors, editors, This Journal staff are free to express responsible positions -even if these views are not in agreement with interests, policies or published research, editorial or commentary of Scivision Publishing Group LLC.

  6. Each Scivision Publishing Group LLC journal has editorial operations that are completely separate and independent.

  7. Any packaging or combined offering of Scivision Publishing Group LLC Journals does not affect the independence of editorial decision-making.

  8. This Journal actively seeks input regarding editorial matters from the physician Editors-in-Chief in an advisory capacity, as well as from the other editorial board members, internal editorial staff, and readers

  9. Editors-in-Chief of This Journal is empowered to create content and commentary free of commercial and organizational influence. All authors and editors operate without conflict of interest and all potential conflicts are disclosed (please also see Conflict of Interest Policy).
 
 
Most Viewed Article
  • Pomalidomide-Associated Progressive Multifocal Leukoencephalopathy (PML) in a Patient with IgG-κ Multiple Myeloma (MM)
    Cassataro G, Smorlesi G, Miceli G, Ruscica F, Alaimo V, Volpe V, Burlon R, Fertitta E, Canale C, Tomaiuolo L, Stella M, Grimaldi LM, Renda M.
    » Abstract » doi: 10.33425/2832-4226/23011

  • The Prevalence of Coronary Artery Disease in Amyloidosis Is 23%
    Lucianne Alers Sanchez, Napatkamon Ayutyanont, Erica Junqueira, Farzad Majidi, Hossein Akhondi.
    » Abstract » doi: 10.33425/2832-4226/23010

  • Haematological Profiles of Plasmodium-Induced Changes in Serum Amyloid-A levels among the Internally Displaced Persons in Maiduguri
    EZE Chinwe N, EBENEZER Amawulu.
    » Abstract » doi: 10.33425/2832-4226/23009

  • Gastritis, Gastropathy and Gastroprotection: What is Common and what are the Differences
    Marakhouski Yury, Rubens Juris.
    » Abstract » doi: 10.33425/2832-4226/23008

  • Mesenchymal Stem Cell-Based Therapy: Targeting Triple-Negative Breast Cancer
    Heather A. Domby, Vincent S. Gallicchio.
    » Abstract » doi: 10.33425/2832-4226/23007

Most Downloaded
  • Pomalidomide-Associated Progressive Multifocal Leukoencephalopathy (PML) in a Patient with IgG-κ Multiple Myeloma (MM)
    Cassataro G, Smorlesi G, Miceli G, Ruscica F, Alaimo V, Volpe V, Burlon R, Fertitta E, Canale C, Tomaiuolo L, Stella M, Grimaldi LM, Renda M.
    » Abstract » doi: 10.33425/2832-4226/23011

  • The Prevalence of Coronary Artery Disease in Amyloidosis Is 23%
    Lucianne Alers Sanchez, Napatkamon Ayutyanont, Erica Junqueira, Farzad Majidi, Hossein Akhondi.
    » Abstract » doi: 10.33425/2832-4226/23010

  • Haematological Profiles of Plasmodium-Induced Changes in Serum Amyloid-A levels among the Internally Displaced Persons in Maiduguri
    EZE Chinwe N, EBENEZER Amawulu.
    » Abstract » doi: 10.33425/2832-4226/23009

  • Gastritis, Gastropathy and Gastroprotection: What is Common and what are the Differences
    Marakhouski Yury, Rubens Juris.
    » Abstract » doi: 10.33425/2832-4226/23008

  • Mesenchymal Stem Cell-Based Therapy: Targeting Triple-Negative Breast Cancer
    Heather A. Domby, Vincent S. Gallicchio.
    » Abstract » doi: 10.33425/2832-4226/23007